Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers

[1]  J. Little,et al.  Differing effects of breast cancer 1, early onset (BRCA1) and ataxia‐telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation , 2003, International journal of radiation biology.

[2]  I. Radford.  Chromosomal rearrangement as the basis for human tumourigenesis , 2004, International journal of radiation biology.

[3]  C. Wang,et al.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. , 1999, Science.

[4]  I. Toma-Dasu,et al.  The use of risk estimation models for the induction of secondary cancers following radiotherapy , 2005, Acta oncologica.

[5]  G. Mills,et al.  Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2 , 2002, International journal of cancer.

[6]  S. Seal,et al.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.

[7]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[8]  J. Eyfjord,et al.  Genomic instability and cancer: networks involved in response to DNA damage. , 2005, Mutation research.

[9]  L. Pierce.  The use of radiotherapy after mastectomy: a review of the literature. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Glazer,et al.  Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status , 2002, The Lancet.

[11]  W. Vogel,et al.  Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. , 2000, Cancer research.

[12]  R. Peto,et al.  Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. , 2005, The Lancet. Oncology.

[13]  H. Kampinga,et al.  BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage , 2002, International journal of radiation biology.

[14]  M. Kastan,et al.  BRCA1 Is Required for Common-Fragile-Site Stability via Its G2/M Checkpoint Function , 2004, Molecular and Cellular Biology.

[15]  Peter Devilee,et al.  Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. , 2005, Cancer research.

[16]  R. Wooster,et al.  Gene Expression Profiling after Radiation-Induced DNA Damage Is Strongly Predictive of BRCA1 Mutation Carrier Status , 2004, Clinical Cancer Research.

[17]  R. Eeles,et al.  BRCA1, BRCA2 and their possible function in DNA damage response , 1999, British Journal of Cancer.

[18]  Alexander Kinev,et al.  BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer , 2000, Cell.

[19]  Y. Shiloh.  ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.